Julia Stingl

机构：Johannes Gutenberg University Mainz, Heidelberg University, University Hospital Heidelberg, Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Aachen, Chirurgische Universitätsklinik Heidelberg, Heidelberg University, RWTH Aachen University · ORCID：0000-0002-1566-8156

发表论文 388 篇 · 总被引 23587 次 · h-index 60

代表论文

• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 – Pharmacokinetic, pharmacogenetic and clinical aspects (2026 · Pharmacopsychiatry · 被引 13)
• Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study (2025 · Clinical Pharmacology & Therapeutics · 被引 10)
• Solanidine‐derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients (2025 · British Journal of Clinical Pharmacology · 被引 9)
• Pharmacogenetic guided drug therapy – how to deal with phenoconversion in polypharmacy (2025 · Expert Opinion on Drug Metabolism & Toxicology · 被引 9)
• Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study (2025 · EClinicalMedicine · 被引 6)
• The impact of proton pump inhibitors on brain health based on cross-sectional findings from the Rhineland Study (2024 · Scientific Reports · 被引 6)